TEPADINA

Amneal Pharmaceuticals LLC🇺🇸 United States

FDA Page

Effective Date: Mar 27, 2020
Approval ID: 559e353c-2dc0-16ba-e054-00144ff8d46c
Products: 3 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TEPADINA® safely and effectively. See full prescribing information for TEPADINA®. TEPADINA® (thiotepa) for injection, for intravenous, intracavitary, or intravesical use. nitial U.S. Approval: 1959 TEPADINA® (thiotepa) for injection, for intravenous, intracavitary, or intravesical use. Initial U.S. Approval: 1959

Quick Stats

Total Products3

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.